Two Sigma Ventures, an early-stage venture capital firm, and RA Capital, an American investment firm, led a $33m Series B round in Gameto, a biotechnology company, with participation from Insight Partners, Future Ventures, and BOLD Capital Partners. "I am proud of the strong scientific foundation, driven and high performing team, innovative pipeline and encouraging data that we have cultivated at Gameto, and I am incredibly excited to amplify and build upon this momentum with the addition of leading investors with extensive expertise in reproductive medicine," Dina Radenkovic, Gameto CEO and Co-Founder.